ETERNA THERAPEUTICS INC (ERNA) 4.78 -0.06 (-1.24%)
4.78 -0.06 (-1.24%)
US1140822099 - Common Stock
ETERNA THERAPEUTICS INC4.78
NASDAQ:ERNA (1/30/2023, 7:00:02 PM)-0.06 (-1.24%)
| GICS Sector | Health Care | ||
| GICS Industry | Biotechnology | ||
| Valuation | Growth | ||
| Profitability | Health | ||
| Dividend | |||
| Earnings (Last) | 11-14 2022-11-14/amc | Earnings (Next) | N/A N/A |
| Ins Owners | 18.92% | Inst Owners | N/A |
| Market Cap | 14.06M | Shares | 2.94M |
| PE | N/A | Fwd PE | N/A |
| Dividend Yield | N/A | Analysts | 43.33 |
| IPO | 08-29 1991-08-29 | ||
Stock Screener Links
Nasdaq Stock Screener
Find more stocks on Nasdaq
USA Stock Screener
Find more stocks on the USA
GICS Sector Stock Screener
Find competitors from the same sector on the USA
GICS Industry Stock Screener
Find competitors from the same industry on the USA
Technical Stock Screener
Find stocks with similar TA and Setup ratings on the USA
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Technical Competitors Stock Screener
Find the competitors with the best technical ratings on the USA
Best Technical Setups Competitors Stock Screener
Find the competitors with the best technical and setup ratings on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA
Company Profile
Eterna Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 10 full-time employees. Eterna Therapeutics Inc. is a biopharmaceutical company. The firm is focused on developing advanced therapies using Messenger RNA (mRNA) cell engineering technology. The firm is engaged in developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its product pipeline is based on patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. The company formulates mRNA using lipid nanoparticle (LNP) technology. The ToRNAdo delivery system surrounds and protects the mRNA cargo, enabling delivery into human cells. The firm has licensed a portfolio of over 100 patents covering key cell engineering technologies, including therapeutic gene editing in clinical development. The company has multiple cell and gene-editing therapies in preclinical development for various indications.
Company Info
ETERNA THERAPEUTICS INC
1035 Cambridge Street, Suite 18A
Cambridge MASSACHUSETTS
P: 12125821199.0
Employees: 10
Website: https://eternatx.com/
ERNA News
5 days ago - Seeking AlphaEterna Therapeutics chief medical officer to resign (NASDAQ:ERNA)Roger Sidhu, chief medical officer at Eterna Therapeutics (ERNA), is resigning effective Jan. 31.
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company...
2 months ago - Market News VideoWednesday 12/7 Insider Buying Report: ERNA, GNTYSAN DIEGO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using...
SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using...
3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!
ERNA Twits
Here you can normally see the latest stock twits on ERNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
